| 2023-11-09 | +81.9% | legal | SEC EDGAR | MRAI 8-K: 5.02, 8.01 (SEC Filing) |
| 2023-11-10 | +67.4% | news | InvestorPlace | Why Is Marpai (MRAI) Stock Up 100% Today? - InvestorPlace |
| 2024-05-28 | -65.9% | news | Seeking Alpha | Marpai stock sinks 42% premarket on Nasdaq delisting |
| 2024-05-28 | -65.9% | news | ChartMill | MRAI Stock Chart | MARPAI INC-CLASS A (NASDAQ:MRAI) - ChartMill |
| 2024-11-12 | +53.5% | earnings | Seeking Alpha | Marpai, Inc (MRAI) Q3 2024 Earnings Call Transcript |
| 2024-11-12 | +53.5% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2024-01-18 | +35.1% | executive | Seeking Alpha | Marpai CEO buys 1.1M shares of the company - filing |
| 2024-01-18 | +35.1% | legal | SEC EDGAR | MRAI 8-K: 5.02, 8.01 (SEC Filing) |
| 2024-11-11 | +35.0% | earnings | Seeking Alpha | Marpai GAAP EPS of -$0.30, revenue of $7.01M |
| 2024-03-05 | +34.5% | legal | SEC EDGAR | MRAI 8-K: 8.01 and (SEC Filing) |
| 2024-09-03 | +29.5% | legal | SEC EDGAR | MRAI 8-K: 1.01, 3.02 (SEC Filing) |
| 2026-02-23 | +28.1% | analyst | PR Newswire | Marpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform Expansion |
| 2024-01-17 | +24.7% | legal | SEC EDGAR | MRAI 8-K: 1.01, 3.02 (SEC Filing) |
| 2026-01-23 | +22.1% | legal | SEC EDGAR | MRAI 8-K: 5.02 (SEC Filing) |
| 2023-06-30 | -21.0% | legal | SEC EDGAR | MRAI 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-06-29 | -20.2% | legal | SEC EDGAR | MRAI 8-K: 5.03, 8.01 (SEC Filing) |
| 2022-05-11 | -20.0% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2025-12-01 | -19.7% | news | Stock Titan | Marpai (OTCQX: MRAI) renews Aetna ASA pact, adds Faircost Optimizer tool - Stock Titan |
| 2024-03-08 | +19.5% | legal | SEC EDGAR | MRAI 8-K: 1.01, 3.02 (SEC Filing) |
| 2025-11-12 | -19.2% | earnings | Seeking Alpha | Marpai GAAP EPS of -$0.20, revenue of $4.03M |
| 2025-11-12 | -19.2% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2025-11-12 | -19.2% | legal | SEC EDGAR | MRAI 8-K: 1.01, 3.02 (SEC Filing) |
| 2025-03-27 | -17.7% | earnings | Seeking Alpha | Marpai GAAP EPS of -$0.08, revenue of $6.6M |
| 2025-03-27 | -17.7% | earnings | Seeking Alpha | Marpai targets profitability in 2025 with new initiatives and strategic partnerships |
| 2025-03-27 | -17.7% | earnings | Seeking Alpha | Marpai, Inc. (MRAI) Q4 2024 Earnings Call Transcript |
| 2025-03-27 | -17.7% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2021-11-16 | -16.4% | legal | SEC EDGAR | MRAI 8-K: 8.01 and (SEC Filing) |
| 2025-01-06 | +16.1% | legal | Seeking Alpha | Marpai announces second tranche of growth funding with up to $5M from JGB |
| 2025-01-06 | +16.1% | legal | SEC EDGAR | MRAI 8-K: 1.01, 2.03, 3.02, 8.01 (SEC Filing) |
| 2024-01-12 | -16.1% | executive | Seeking Alpha | Marpai appoints John Powers as its CEO |
| 2024-05-09 | -15.9% | earnings | Seeking Alpha | Marpai GAAP EPS of -$0.46 |
| 2024-05-09 | -15.9% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2022-03-31 | -15.0% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2023-03-29 | +14.7% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2024-04-17 | +14.3% | legal | SEC EDGAR | MRAI 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2022-08-09 | +13.7% | legal | SEC EDGAR | MRAI 8-K: 1.01 and (SEC Filing) |
| 2022-08-25 | -13.6% | legal | SEC EDGAR | MRAI 8-K: 8.01 and (SEC Filing) |
| 2024-06-25 | +13.3% | legal | SEC EDGAR | MRAI 8-K: 8.01 (SEC Filing) |
| 2026-04-01 | +12.9% | legal | PR Newswire | Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide |
| 2026-04-01 | +12.9% | M&A | Stock Titan | Marpai signs 3-year deal to market pharmacy benefits nationwide - Stock Titan |
| 2025-08-04 | +12.6% | legal | SEC EDGAR | MRAI 8-K: 1.01, 3.02 (SEC Filing) |
| 2025-07-21 | +12.3% | legal | SEC EDGAR | MRAI 8-K: 1.01, 3.02 (SEC Filing) |
| 2024-02-08 | +11.7% | expansion | Seeking Alpha | Marpai announces key financial agreements |
| 2024-02-08 | +11.7% | legal | SEC EDGAR | MRAI 8-K: 1.01, 8.01 (SEC Filing) |
| 2025-05-15 | -11.5% | news | Seeking Alpha | Marpai targets cash flow positivity in 2025 with cost reductions and leadership changes |
| 2025-05-15 | -11.5% | earnings | Seeking Alpha | Marpai, Inc. (MRAI) Q1 2025 Earnings Call Transcript |
| 2026-02-13 | -10.9% | legal | SEC EDGAR | MRAI 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-12-23 | -10.6% | legal | SEC EDGAR | MRAI 8-K: 1.01, 3.02 (SEC Filing) |
| 2026-04-08 | +10.5% | M&A | Stock Titan | Marpai (MRAI) director receives 100,000 RSUs tied to strategic deal - Stock Titan |
| 2023-06-01 | -10.5% | legal | SEC EDGAR | MRAI 8-K: 5.02 and 5.07 (SEC Filing) |
| 2023-06-01 | -10.5% | legal | SEC EDGAR | MRAI 8-K: 8.01 and (SEC Filing) |
| 2025-09-16 | -10.3% | legal | SEC EDGAR | MRAI 8-K: 1.01, 3.02 (SEC Filing) |
| 2024-05-14 | -10.1% | legal | SEC EDGAR | MRAI 8-K: 5.02 (SEC Filing) |
| 2024-05-02 | +9.8% | news | Seeking Alpha | Marpai to implement cost reduction measures |
| 2024-12-10 | +9.2% | legal | SEC EDGAR | MRAI 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2025-05-14 | -9.0% | earnings | Seeking Alpha | Marpai GAAP EPS of -$0.21, revenue of $5.4M |
| 2025-05-14 | -9.0% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2023-12-11 | -8.7% | legal | SEC EDGAR | MRAI 8-K: 5.02 and (SEC Filing) |
| 2025-03-26 | -8.5% | earnings | Seeking Alpha | Marpai GAAP EPS of -$0.08, revenue of $6.59M |
| 2023-11-13 | -8.4% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2023-04-19 | -8.2% | legal | SEC EDGAR | MRAI 8-K: 1.01, 8.01 (SEC Filing) |
| 2021-12-20 | -8.0% | legal | SEC EDGAR | MRAI 8-K: 3.02, 8.01 (SEC Filing) |
| 2022-02-15 | +7.1% | legal | SEC EDGAR | MRAI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-13 | -6.9% | earnings | Seeking Alpha | Marpai, Inc. (MRAI) Q3 2025 Earnings Call Transcript |
| 2023-08-17 | +6.9% | legal | SEC EDGAR | MRAI 8-K: 5.02 and (SEC Filing) |
| 2024-08-11 | -6.7% | earnings | Seeking Alpha | Marpai, Inc. (MRAI) Q2 2024 Earnings Call Transcript |
| 2022-05-31 | -6.5% | legal | SEC EDGAR | MRAI 8-K: 5.02 and 5.07 (SEC Filing) |
| 2025-08-13 | -6.4% | earnings | Seeking Alpha | Marpai GAAP EPS of -$0.28, revenue of $4.6M |
| 2025-08-13 | -6.4% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2024-03-06 | +6.3% | earnings | Seeking Alpha | Marpai reports Q4 results |
| 2024-03-06 | +6.3% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2024-03-06 | +6.3% | legal | SEC EDGAR | MRAI 8-K: 8.01 and (SEC Filing) |
| 2023-08-03 | -6.0% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2026-03-09 | +5.7% | legal | PR Newswire | Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives |
| 2024-05-10 | -5.6% | earnings | Seeking Alpha | Marpai, Inc. (MRAI) Q1 2024 Earnings Call Transcript |
| 2024-03-13 | +5.2% | legal | SEC EDGAR | MRAI 8-K: 8.01 and (SEC Filing) |
| 2024-05-06 | +4.8% | legal | SEC EDGAR | MRAI 8-K: 5.02 and 5.07 (SEC Filing) |
| 2023-12-13 | +4.6% | legal | SEC EDGAR | MRAI 8-K: 5.02, 8.01 (SEC Filing) |
| 2022-02-22 | -4.4% | legal | SEC EDGAR | MRAI 8-K: 5.02 (SEC Filing) |
| 2021-12-09 | +4.4% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2023-02-07 | +4.4% | legal | SEC EDGAR | MRAI 8-K: 5.02, 8.01 (SEC Filing) |
| 2022-08-04 | -4.1% | legal | SEC EDGAR | MRAI 8-K: 8.01 and (SEC Filing) |
| 2023-05-10 | -4.1% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2023-12-06 | +3.6% | legal | SEC EDGAR | MRAI 8-K: 8.01 and (SEC Filing) |
| 2026-04-19 | -3.2% | news | Minichart | Marpai, Inc. (MRAI) - Minichart |
| 2022-11-01 | +2.9% | legal | SEC EDGAR | MRAI 8-K: 2.01, 8.01 (SEC Filing) |
| 2022-11-09 | +2.6% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2021-11-01 | -2.5% | legal | SEC EDGAR | MRAI 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-03-11 | -2.4% | legal | SEC EDGAR | MRAI 8-K: 1.01, 2.03 (SEC Filing) |
| 2024-03-27 | +2.1% | earnings | Seeking Alpha | Marpai, Inc. (MRAI) Q4 2023 Earnings Call Transcript |
| 2022-08-10 | -2.0% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2024-08-07 | -1.6% | earnings | Seeking Alpha | Marpai GAAP EPS of -$1.23, revenue of $7.2M |
| 2024-08-07 | -1.6% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2024-08-07 | -1.6% | earnings | InvestorPlace | MRAI Stock Earnings: Marpai Misses EPS, Beats Revenue for Q2 2024 - InvestorPlace |
| 2024-05-30 | -1.6% | news | Seeking Alpha | Marpai files to sell 3.94M shares of common stock for holders |
| 2022-08-26 | -1.5% | news | Yahoo Finance | The Director of Marpai, Inc. (NASDAQ:MRAI), Damien Lamendola, Just Bought 12% More Shares - Yahoo Finance |
| 2024-12-05 | +1.4% | news | Seeking Alpha | Marpai announces pricing of $700,000 private placement |
| 2023-02-01 | +1.4% | legal | SEC EDGAR | MRAI 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-08-29 | +1.3% | legal | SEC EDGAR | MRAI 8-K: 5.02 (SEC Filing) |
| 2025-10-06 | +1.3% | executive | Seeking Alpha | Marpai raises $200K in private placement with CEO-backed HillCour Investment |
| 2025-10-06 | +1.3% | legal | SEC EDGAR | MRAI 8-K: 1.01, 3.02 (SEC Filing) |
| 2025-10-06 | +1.3% | news | PR Newswire | MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUND - PR Newswire |
| 2024-03-26 | +1.3% | earnings | Seeking Alpha | Marpai GAAP EPS of -$0.65 misses by $0.38, revenue of $8.71M beats by $0.3M |
| 2024-03-26 | +1.3% | legal | SEC EDGAR | MRAI 8-K: 2.02 and (SEC Filing) |
| 2026-01-27 | +1.2% | news | PR Newswire | MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH |
| 2025-02-06 | +1.1% | legal | SEC EDGAR | MRAI 8-K: 1.01 and (SEC Filing) |
| 2023-12-15 | -1.0% | legal | SEC EDGAR | MRAI 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2023-01-10 | -0.9% | legal | SEC EDGAR | MRAI 8-K: 2.01 and (SEC Filing) |
| 2025-08-14 | +0.5% | earnings | Seeking Alpha | Marpai targets profitability in Q1 2026 as MarpaiRx relaunch accelerates transformation |
| 2025-08-14 | +0.5% | earnings | Seeking Alpha | Marpai, Inc. (MRAI) Q2 2025 Earnings Call Transcript |
| 2023-07-17 | +0.1% | legal | SEC EDGAR | MRAI 8-K: 8.01 (SEC Filing) |
| 2025-05-13 | -0.0% | legal | SEC EDGAR | MRAI 8-K: 5.02, 8.01 (SEC Filing) |